AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

January 24, 2023
COST-EFFECTIVENESS OF OMALIZUMAB FOR THE TREATMENT OF SEVERE PEDIATRIC ALLERGIC ASTHM...
Antonio Nieto, María Nieto-Cid, Teresa Garriga-Baraut, et al.
January 11, 2023
“Soluble form of the receptor for advanced glycation end products (sRAGE) as a marker...
Cristina De Manuel, Verónica Sanz-Santiago, Alejandro López-Neyra, et al.
December 03, 2022
Mechanisms of ventilatory limitation to maximum exercise in children and adolescents...
Margarita Perez Ruiz, Márcio Vinícius Fagundes Donadio, Marta Amor Barbosa, et al.
October 29, 2020
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent al...
Antonio Nieto García, Teresa Garriga-Baraut, Ana Maria Plaza, et al.